AbCellera Biologics Inc. Annual Operating Income (Loss) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
AbCellera Biologics Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2019 to 2023.
  • AbCellera Biologics Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$93.7M, a 70.6% decline year-over-year.
  • AbCellera Biologics Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$308M, a 47.4% decline year-over-year.
  • AbCellera Biologics Inc. annual Operating Income (Loss) for 2023 was -$237M, a 210% decline from 2022.
  • AbCellera Biologics Inc. annual Operating Income (Loss) for 2022 was $217M, a 5.92% increase from 2021.
  • AbCellera Biologics Inc. annual Operating Income (Loss) for 2021 was $204M, a 31% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$237M -$454M -210% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-20
2022 $217M +$12.1M +5.92% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-20
2021 $204M +$48.4M +31% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-20
2020 $156M +$160M Jan 1, 2020 Dec 31, 2020 10-K 2023-02-21
2019 -$4.12M Jan 1, 2019 Dec 31, 2019 10-K 2022-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.